2014/0183(NLE)

Subjecting 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921), 3,4-methylenedioxypyrovalerone (MDPV) and 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine) to control measures

Basic information

2014/0183(NLE)

NLE - Non-legislative enactments

Decision

See also Decision 2005/387/JHA 2003/0215(CNS)

Subject

7.30.30.04 Action to combat drugs and drug-trafficking

Status

Procedure completed

Key players

Key events

Date Event Reference Summary
16/06/2014 Initial legislative proposal published COM(2014)0362
30/06/2015 Legislative proposal published 10011/2015
09/07/2015 Committee referral announced in Parliament
22/09/2015 Vote in committee
28/09/2015 Committee report tabled for plenary, 1st reading/single reading A8-0264/2015
06/10/2015 Decision by Parliament T8-0328/2015
06/10/2015 Results of vote in Parliament
08/10/2015 Act adopted by Council after consultation of Parliament
08/10/2015 End of procedure in Parliament
20/10/2015 Final act published in Official Journal

Technical information

Procedure reference 2014/0183(NLE)
Procedure type NLE - Non-legislative enactments
Procedure subtype Consultation of Parliament
Legislative instrument Decision
See also Decision 2005/387/JHA 2003/0215(CNS)
Legal basis Treaty on the European Union (after Amsterdam) M 039-p1
Other legal basis Rules of Procedure EP 165
Stage reached in procedure Procedure completed
Committee dossier LIBE/8/03857

Documentation gateway

  • Document type Committee Reference Date Summary
    Committee draft report PE564.981 01/09/2015
    Committee report tabled for plenary, 1st reading/single reading A8-0264/2015 28/09/2015
    Text adopted by Parliament, 1st reading/single reading T8-0328/2015 06/10/2015
  • Document type Reference Date Summary
    Legislative proposal 10011/2015 30/06/2015
  • Document type Reference Date Summary
    Initial legislative proposal COM(2014)0362 16/06/2014